Trial Profile
A Phase 0 Open-labelled Clinical Trial To Investigate The Safety of a Micro-dose of a Nanocelle'Trademark' Insulin Formulation Administered Oro-buccally in Healthy Adult Volunteers.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase 0
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Medlab
- 17 Jul 2017 New trial record